COVID-19 News Updates

10,98,62,585 persons in the age group of 18-44 years across 37 states/UTs have received their first dose, while 35,08,932 persons have received their second dose since the start of the Phase-3 of the vaccination drive.

As per the data released by Union Health Ministry, Odisha will receive 40,67,870 doses in July. The State was allocated nearly 37 lakh doses in June

Data shows the second wave surge in Odisha was preventable. Because when the virus was on a growth spree, the State administration failed to enforce the Covid-19 appropriate behaviour. Virus transmission peaked in mid-March to April first week. But restrictions were brought in from mid-April 

NITI Aayog member (Health) Dr V K Paul said, "Moderna vaccine is under emergency use authorisation. The government is working actively with the manufacturers to see how to make this vaccine available in the country.

Under-18s are not routinely offered Covid vaccines, even if they have other underlying health conditions that put them at risk.

The government has already clarified that Covid-19 vaccines are safe for pregnant women and the special inoculation drive will be carried out as per the guidelines issued.

MSN labs will be launching the 2 DG as a twice a day product in sachet form under the brand name MSN 2D in strength of 2.34 g.

India has 4,58,727 active cases presently and has witnessed a total of 4,05,939 deaths so far.

The Covid positive tally in Odisha also rose to 9,35,136 after as many as 2,806 people tested positive for the virus on Friday

The US continues to be the worst-hit country with the world's highest number of cases and deaths at 33,790,136 and 606,468, respectively, according to the CSSE.

In August, Pfizer plans to ask the Food and Drug Administration for emergency authorization of a third dose.

While the SBI report empirically observed that most low-income states have low Covid-19 deaths, the AIIMS-Patna study and international experts link it to higher immunity among populations in lower strata and low life expectancy  

2-DG was developed by the Defence Research and Development Establishment (DRDE), Gwalior. The clinical trials were conducted by the Institute of Nuclear Medicine and Allied Sciences (INMAS).

Covid-19 vaccines are safe for pregnant women and as per the guidelines issued by the Union Health Ministry their vaccination will start in Odisha soon

Children below 18 years are likely to be affected more during the possible third wave as predicted by public health experts and the State Government is fully ready to tackle the situation